Akanda Corp. (AKAN) vs IM Cannabis Corp. (IMCC)

Akanda Corp. and IM Cannabis Corp. are both Drug Manufacturers Specialty & Generic companies. Akanda Corp. is the larger, with a market value of $3.5M against $2.2M — 1.6× the size. Across the 9 metrics below, Akanda Corp. leads on 6 and IM Cannabis Corp. on 3.

Valuation

Metric AKAN IMCC Drug Manufacturers Specialty & Generic median
P/E — n/m 19.25
P/S n/m 0.01 2.11
P/B n/m n/m 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m n/m 12.58
EV/Sales n/m 0.00 2.73
Earnings yield — (5,660.48%) (4.38%)
Free cash flow yield 0.00% (115.96%) 0.00%

Profitability

Metric AKAN IMCC Drug Manufacturers Specialty & Generic median
Gross margin — 12.62% 53.94%
Operating margin — (32.88%) 0.00%
Net margin — (38.92%) 0.00%
Free cash flow margin 0.00% (1.47%) 0.00%
Return on equity 0.00% 2,280.06% (0.40%)
Return on assets 0.00% (54.20%) (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AKAN IMCC Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (11.97%) 10.01%
EPS growth (last fiscal year) (139.63%) 41.95% 49.06%
Revenue growth, 5-year CAGR 161.77% 26.99% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AKAN IMCC Drug Manufacturers Specialty & Generic median
Debt to equity (0.70) (0.12) 0.05
Current ratio 0.22 0.56 2.31
Net debt to EBITDA (2.75) 0.18 0.97

Dividend

Metric AKAN IMCC Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric AKAN IMCC Drug Manufacturers Specialty & Generic median
Market cap 3.45m 2.19m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack